Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 41(12): 1566-8, 2014 Nov.
Article in Japanese | MEDLINE | ID: mdl-25731254

ABSTRACT

There is insufficient evidence for the pre-operative use of chemoradiotherapy (CRT) in treatment of advanced rectal cancers, and its efficiency and safety are unclear. However, it has recently been suggested that a new class of carcinostatic agents are more effective during preoperative CRT. Under the National Comprehensive Cancer Network (NCCN) guidelines, 5-FU and capecitabine have been recommended as the standard drugs for use during combination chemoradiotherapy. The Japanese Society for Cancer of Colon and Rectum (JSCCR) guidelines for 2014 also recommend the use of both drugs during preoperative CRT. We report a case of rectal cancer, which was successfully treated with radical resection and neoadjuvant chemoradiotherapy.


Subject(s)
Adenocarcinoma/therapy , Antimetabolites, Antineoplastic/therapeutic use , Chemoradiotherapy , Deoxycytidine/analogs & derivatives , Fluorouracil/analogs & derivatives , Rectal Neoplasms/therapy , Adenocarcinoma/complications , Aged, 80 and over , Capecitabine , Deoxycytidine/therapeutic use , Fluorouracil/therapeutic use , Humans , Ileus/etiology , Male , Neoplasm Staging , Rectal Neoplasms/complications , Rectal Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...